Page last updated: 2024-11-02

pioglitazone and Temporomandibular Disorders

pioglitazone has been researched along with Temporomandibular Disorders in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Turosz, N1
Chęcińska, K1
Chęciński, M1
Kamińska, M1
Nowak, Z1
Sikora, M1
Chlubek, D1
Henney, JE1

Reviews

1 review available for pioglitazone and Temporomandibular Disorders

ArticleYear
A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis.
    International journal of environmental research and public health, 2022, 12-09, Volume: 19, Issue:24

    Topics: Animals; Arthritis, Rheumatoid; Inflammation; Pioglitazone; Temporomandibular Joint; Temporomandibul

2022

Other Studies

1 other study available for pioglitazone and Temporomandibular Disorders

ArticleYear
From the Food and Drug Administration.
    JAMA, 1999, Sep-08, Volume: 282, Issue:10

    Topics: Diabetes Mellitus, Type 2; Endotoxemia; Gentamicins; Humans; Hypoglycemic Agents; Joint Prosthesis;

1999